Warby Parker (WRBY) Stock Soars on Google AI Glasses Timeline: Price Action, Earnings and 2026 Forecasts as of December 8, 2025
Updated December 8, 2025 Warby Parker Inc. is suddenly trading like an AI story, not just an eyewear retailer.
Arrowhead Pharmaceuticals (ARWR) Soars to Fresh Highs on Alzheimer’s Trial and FDA Breakthrough Wins
Arrowhead Pharmaceuticals, Inc. is finishing 2025 with the kind of momentum small-molecule biotechs daydream about. On 8 December 2025, the RNA interference specialist climbed to a new 52‑week high near $69 per share after the company announced it had dosed the first subjects in its Alzheimer’s disease trial ARO‑MAPT and highlighted a string of recent FDA victories and deal-driven cash inflows. Arrowhead Pharmaceuticals, Inc.+2MarketBeat+2 The rally caps a stunning year in which Arrowhead stock has delivered a year‑to‑date return of roughly 270% and a one‑year gain in the 160–200% range, depending on the data provider, vastly outpacing the broader market. Yahoo Finance+2Market Chameleon+2
MercadoLibre (MELI) Stock Today: December 8, 2025 Update on Price, Q3 Results, Bond Deal and Analyst Forecasts
As of Monday, December 8, 2025, MercadoLibre, Inc. remains one of the most closely watched growth stocks in emerging markets. The Latin American e‑commerce and fintech leader is trading a little above $2,080 per share, giving it a market capitalization of roughly $105–108 billion, with a 52‑week range of $1,646 to $2,645 and a trailing P/E around 50–51. StockAnalysis+1 Yet despite strong fundamentals, the stock has fallen about 15–16% over the last six months, underperforming its e‑commerce peers as investors fret over margin pressure, intense competition and macro volatility in Latin America. Finviz
Nurix Therapeutics (NRIX) Stock Soars on ASH 2025 Trial Data: Latest News, Analyst Forecasts and Outlook as of December 8, 2025
Nurix Therapeutics, Inc. is back in the spotlight. On December 8, 2025, the biotech stock surged roughly 20% intraday after the company released new Phase 1 data for its Bruton’s tyrosine kinase degrader bexobrutideg in blood cancers at the American Society of Hematology Annual Meeting and scheduled a corporate webcast for this evening. MarketBeat+3GlobeNewswire+3GlobeNewswire+3 The rally comes barely two months after Nurix posted a weak third quarter and executed a large equity raise, underscoring how heavily sentiment in this name is tied to the clinical trajectory of its degrader pipeline. ChartMill+2StockAnalysis+2
Carvana (CVNA) Soars on S&P 500 Inclusion: Latest News, Stock Forecast and Analysis as of December 8, 2025
Carvana Co. is back in the spotlight. On Monday, December 8, 2025, the online used-car retailer’s shares surged again after S&P Dow Jones Indices confirmed that Carvana will join the benchmark S&P 500 index on December 22, 2025. The stock traded around $454 in late session, up roughly 14% on the day and near record highs, capping a year in which the stock has gained well over 100% and staged one of the most dramatic recoveries in recent market history. Reuters According to Reuters, Carvana’s market value has swelled to roughly $87 billion, now exceeding both Ford and General Motors, and the shares trade at about 57 times forward earnings — a valuation more typical of high‑growth software than a used-car dealer. Reuters
Kymera Therapeutics (KYMR) Stock Soars on KT‑621 Eczema Data: What December 8, 2025 Means for Investors
Kymera Therapeutics, Inc. delivered one of the biggest biotech moves on Wall Street today. On Monday, December 8, 2025, Kymera stock surged more than 40% intraday, trading around $96 late in the session after touching an intraday high above $100, on volume far above normal. MarketBeat The catalyst: very strong Phase 1b data for KT‑621, a once‑daily oral STAT6 degrader for atopic dermatitis and broader Type 2 inflammatory diseases. GlobeNewswire
Wave Life Sciences (WVE) Stock Explodes on Obesity Drug Breakthrough – What the New Data and Wall Street Forecasts Signal
Published: December 8, 2025 Wave Life Sciences Ltd. staged a spectacular rally on Monday after unveiling positive interim data from its Phase 1 INLIGHT trial for obesity drug candidate WVE‑007. Shares surged from a close of $7.49 on Friday, December 5 to intraday levels around $17–18, a gain in the range of 120%–140% and a new multi‑year high. Yahoo Finance+2Investing.com+2
Confluent (CFLT) Soars on IBM’s $11 Billion Takeover: Deal Terms, Stock Outlook and Analyst Forecasts After December 8, 2025 Rally
Confluent, Inc. has suddenly shifted from a high-growth data‑infrastructure story to a classic M&A arbitrage play. On December 8, 2025, IBM and Confluent announced a definitive agreement under which IBM will acquire all outstanding Confluent shares for $31 in cash, valuing the data‑streaming specialist at around $11 billion enterprise value.IBM Newsroom+2ABC News+2
Banco Bradesco (BBD) Stock on December 8, 2025: Is the Post‑Earnings Sell‑Off a Buying Opportunity?
Published: December 8, 2025 – Informational article, not investment advice. Banco Bradesco S.A., Brazil’s second‑largest private bank and a diversified financial and insurance group, is back under the market microscope. Its NYSE‑listed ADRs trade around $3.35 on December 8, 2025, up slightly on the day and sitting close to the upper half of their 52‑week range between $1.84 and $3.77. Investing
Boeing (BA) Stock Today: Spirit AeroSystems Deal Closes as Wall Street Sees Double‑Digit Upside
Published: December 8, 2025 – All data as of this date. This article is for informational purposes only and is not investment advice. Boeing shares are trading around $206 per share on December 8, 2025, up roughly 2% on the day as investors react to a major supply‑chain acquisition and a more optimistic multi‑year outlook. StockAnalysis
Vertiv Stock (VRT) on December 8, 2025: AI Data‑Center Darling Faces High Expectations After New Deals, Upgrades and a Dividend Hike
Published: December 8, 2025 Vertiv Holdings Co goes into the second week of December as one of Wall Street’s most closely watched AI‑infrastructure names. A powerful multi‑year rally, booming demand for AI data centers, a fresh $1 billion acquisition and multiple analyst upgrades have pushed the stock near record territory—while also raising the bar for future execution. TradingView+2Wikipedia+2
Rigetti Computing (RGTI) Stock: December 8, 2025 News, Analyst Forecasts and Quantum Computing Outlook
As of market close on December 8, 2025, Rigetti Computing, Inc. trades around $27.84 per share, down roughly 1% on the day, for a market capitalization of about $9.3 billion. The stock has swung between $3.31 and $58.15 over the past year and remains up several hundred percent year‑on‑year despite a violent November correction. Stocktwits+1 This article rounds up the latest news, forecasts and analysis available as of December 8, 2025, to help investors understand what’s really driving Rigetti’s hyper‑volatile quantum computing stock.
Wimbledon Station Incident Today: Man Dies as Emergency on Line Triggers Major Rail Chaos Between London and Surrey
London, Monday 8 December 2025 – A man has died after a major emergency incident near Wimbledon station that has shut key rail lines between London and Surrey, leaving thousands of commuters stranded and causing disruption expected to last all day, according to National Rail and train operators. National Rail+1 The incident was first reported near the railway in the Wimbledon area at around 2.27pm on Monday 8 December 2025, with National Rail logging the event at 14:27 and confirming that emergency services were on scene. National Rail+1
Spirit AeroSystems (SPR) Stock on December 8, 2025: Boeing Takeover, NYSE Delisting and What Shareholders Get
Spirit AeroSystems Holdings, Inc. has effectively reached the end of its life as a standalone public stock. On December 8, 2025, Boeing officially completed its acquisition of Spirit AeroSystems, halted trading in SPR, and kicked off the process to delist the shares from the New York Stock Exchange.Boeing Investors+1
Reddit (RDDT) Stock Today – December 8, 2025: AI Data Goldmine, r/popular Shake‑Up and What Analysts Expect Next
Reddit, Inc. is closing out 2025 with the kind of momentum most newly public tech companies can only dream of. The stock has almost doubled in the past six months, analysts are racing to lift price targets, and Wall Street is suddenly treating Reddit’s 20 years of user‑generated chatter as prime training fuel for artificial intelligence. Finviz+1 At the same time, management is ripping out one of the site’s most iconic features — the r/popular feed — and insiders are cashing in shares after a blowout earnings year. That cocktail of rapid growth, product upheaval, AI upside and insider selling makes Reddit one of the most hotly debated media and AI names in the market right now.
UK Stock Market Today: FTSE 100 Dips as Unilever Slumps on Magnum Spin‑Off (London Close, 8 December 2025)
The UK stock market started the new week on the back foot on Monday, 8 December 2025, as investors juggled a landmark Unilever spin‑off, a renewed bond sell‑off and looming interest‑rate decisions from both the US Federal Reserve and the Bank of England. By the closing bell in London, the FTSE 100 had slipped around 0.2% to 9,645.09, while the FTSE 250 fell 0.7% to 21,921.28 and the AIM All‑Share lost 0.4% to 748.52. Alternative benchmarks told a similar story, with the Cboe UK 100 down 0.2%, the Cboe UK 250 off 0.6% and Cboe Small Companies down 0.9%. London South East
DAX Today After the Bell: German Stock Market Edges Higher as Bayer and Kloeckner Rally – December 8, 2025
Germany’s stock market started the new week on a cautious but broadly positive note. The DAX 40 finished Monday’s session just above the 24,000‑point mark, with modest gains driven by pharmaceuticals and defence stocks, even as real estate and consumer names weighed on the broader European market. Investing.com UK+1 Investors digested a stronger‑than‑expected German industrial production report, ongoing worries about the country’s weak growth outlook, and fresh takeover speculation in the steel sector – all under the shadow of this week’s pivotal U.S. Federal Reserve meeting.
Rivian Stock on December 8, 2025: Downgrade, Recall and R2 Hopes – What RIVN Investors Need to Know
Rivian Automotive, Inc. is back in the market spotlight today, and not in a quiet way. As of Monday afternoon, Rivian shares were trading around $17.30, down roughly 3–5% on the day, with intraday trading between about $17.05 and $17.70. That pullback comes after a strong rally from the April 2024 low of about $8.26 and a 12‑month gain in the high 30% range, even though the stock is still down roughly 90% from its 2021 peak near $172.FinancialContent+1
Canada Stock Market Today: TSX Slips Near 31,270 as Energy, Utilities and Telecom Drag Ahead of BoC Decision (Dec. 8, 2025, ~1 p.m. ET)
Canada’s stock market cooled slightly by early afternoon on Monday, with the S&P/TSX Composite Index drifting just below record territory as investors turned their focus squarely to this week’s central‑bank decisions in Canada and the United States. By late morning, around 12:40 p.m. ET, the S&P/TSX Composite was down about 44 points, trading near 31,268, as losses in telecom, utilities and energy weighed on the benchmark, while U.S. markets were also modestly lower. CityNews Halifax That pullback leaves the index only a short distance from last week’s record close around 31,542, after a year in which Canadian equities have delivered roughly 25–27% total returns, putting the TSX among the stronger performers in developed markets. TechStock²+1
US Stock Market Today at 1 PM ET: Wall Street Slips From Record Highs as Fed Week, Mega-Deals and AI Trades Collide
U.S. stocks spent Monday’s early afternoon drifting lower from record territory, as Wall Street balanced a pivotal Federal Reserve meeting, a blockbuster bidding war for Warner Bros. Discovery and fresh deal-making in the AI infrastructure space. By around 12:45–1:00 p.m. Eastern time on Monday, December 8, 2025, the S&P 500 was down roughly 0.4–0.5%, trading just under 6,850. The Dow Jones Industrial Average slipped about 0.4–0.5%, while the Nasdaq Composite was off about 0.3%. The small‑cap Russell 2000 was one of the few bright spots, holding a modest gain of about 0.2%.Google+2Kiplinger+2
Latest Market Updates
